In contrast, in the hippocampus of mice after therapeutic intervention with AS, it can be found that mice in the AS group have a significant decrease in the expression level of TRAF6 protein and a notable increase in the expression level of MAPK phosphorylation and the HSP27 protein compared with the AD group; all the results were significant (Figure 4B). This evidence concerns the gene TRAF6 and Alzheimer disease.